USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
GENELABS TECHNOLOGIES, INC.
Address:
505 PENOBSCOT DRIVE
Redwood City, CA 94063
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $702,170.00 11
SBIR Phase II $2,520,228.00 5

Award List:

HUMAN MONOCLONAL ANTIBODIES TO HLA-DR DETERMINANTS

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Dr Paul Wu
Abstract:
N/a

HUMAN MONOCLONAL ANTIBODIES TO HLA-DR DETERMINANTS

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Dr Paul Wu
Abstract:
The human immune response is governed by ordered interactions between functionally and phenotypically distinct lympoid cells (t cells and their subsets, b cells) and monocytes in the context of ia-like molecules encoded by the hla complex of genes. thus,the products of these hla class ii genes… More

IDENTIFICATION AND ISOLATION OF THE CYSTIC FIBROSIS GENE

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Kirk e fry phd
Abstract:
Complete and partial restriction-enzyme digests of genomic dna will be analyzed by pfge to map the known dna markers linked to the gene for cystic fibrosis. these techniques will be used to identify large dna fragments that span the chromosomal site of the cystic fibrosis gene. these fragments will… More

"STUDY OF LINKED GROWTH FACTOR GENES ON CHROMOSOME 5"

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

INHIBITORS OF INTERLEUKIN

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

RANDOM RECEPTOR MIMITOPE LIBRARY

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Michael Piatak
Abstract:
Mimetic drugs comprise an important part of the pharmacopoeia. they work by binding to receptors for hormones or other physiological mediators and either block (antagonize) or mimic (agonize) the effect of the natural ligand. conventional methods for finding mimetic drugs are exceedingly expensive,… More

A NOVEL ASSAY FOR THE DETECTION OF ANTIVIRAL DRUGS

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Cynthia Edwards
Abstract:
N/a

ASSAY DEVELOPMENT OF DIAGNOSTIC TESTS FOR HEPATITIS E.

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$50,000.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Patrice Yarborough, PH.D. , PRINCIPAL INVESTIGATOR
Abstract:
N/a

"STUDY OF LINKED GROWTH FACTOR GENES ON CHROMOSOME 5"

Award Year / Program / Phase:
1991 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Abstract:
We propose to isolate new growth factor or growth factor receptor genes, based upon their linkage to a cluster of such genes on human chromosome 5. a long range comparative physical map of the known genes within this region will be compiled, and large dna fragments on which two or more of these… More

INHIBITORS OF INTERLEUKIN

Award Year / Program / Phase:
1991 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Abstract:
This research will identify and clone endogenous inhibitory molecules of interleukin-1 (il-1). human immunodeficiency virus (hiv)-infected macrophages and macrophage cell lines release two inhibitors of il-1, an 8-kd molecule and a 95-kd molecule. poly (a)(+) mrna will be prepared from these sources… More

A NOVEL ASSAY FOR THE DETECTION OF ANTIVIRAL DRUGS

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$473,046.00
Agency:
HHS
Principal Investigator:
Cynthia Edwards
Abstract:
Viral proliferation requires the interaction of viral regulatory proteins with their cognate recognition sequenceswithin the viral genome. this research seeks to identify small molecules that will interfere with these dna protein interactions by binding in a sequence-specific manner to the dna… More

ASSAY DEVELOPMENT OF DIAGNOSTIC TESTS FOR HEPATITIS E.

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$547,182.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Patrice Yarborough, PH.D. , PRINCIPAL INVESTIGATOR
Abstract:
N/a

Recombinant HEV-Like Particles as a Potential Vaccine

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$77,900.00
Agency:
HHS
Principal Investigator:
Patrice Yarbough
Abstract:
Hepatitis E virus (HEV) infections represent a major health problem in developing countries whereepidemics primarily affect young to middle-age adults. Although HEV does not lead to chronic hepatitisor cirrhosis, the infection is severe enough to warrant prevention. We will demonstrate that the… More

Development of a Cell Culture System for HIV Infection

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$78,960.00
Agency:
HHS
Principal Investigator:
Albert Tam
Abstract:
Hepatitis E virus (HEV) is the major etiologic agent for enterically transmitted non-A, non-Bhepatitis. Hepatitis E represents more than half of the acute viral hepatitis cases occurring in developingcountries where large epidemics affect young to middle-aged adults. Systematic studies on… More

DEVELOPMENT OF IMMUNOASSAY FOR HGV

Award Year / Program / Phase:
1996 / SBIR / Phase I
Award Amount:
$93,852.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

NOVEL PUTATIVE ASTHMA/ATOPY GENES IN HUMAN CHROMOSOME 5

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$101,458.00
Agency:
HHS
Principal Investigator:
Dolganov, Gregory M
Abstract:
N/a